{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T04:34:54Z","timestamp":1774672494396,"version":"3.50.1"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[1990,10,1]],"date-time":"1990-10-01T00:00:00Z","timestamp":654739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,6,28]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>The activity of both cytotoxic T lymphocyte (CTL) and natural killer (NK) cells were measured cross-sectionally in 43 subjects seropositive for HIV, in 27 HIV- blood donors and in 24 HIV persons from the Outpatients Clinic for sexually transmitted diseases. CTL activity was evaluated using the HL-60 cells coated with OKT3 as the targets and freshly separated peripheral blood lymphocytes as the effectors. In 20 out of 43 HIV+ subjects, CTL activity was significantly enhanced in comparison to the HIV subjects. This lytic activity correlated positively with the percentages of CD3+ HLA-DR+, of CD8+ CR3- and of CD57+CD16- lymphocytes, and was greatly reduced after elimination of CD8+ of HLA-DR+ or of CD57+ cells. The median CTL activity seemed to increase from CDC group II to CDC group IV (Centers for Disease Control classification), but to return back to control levels in those patients with a history of opportunistic infections. NK function in HIV+ subjects was not significantly different from that in the blood donors. In seropositive patients, NK activity correlated positively with the percentages of both CD16+CD57+ and of CD8+ CR3+ cells and was strongly diminished after elimination of CD16 + or of CD57+ cells. There was no significant change in NK function according to the clinical stage. The data show that circulating CD8+HLA-DR+ CTJ57+ T cells in HIV+ subjects are activated cytotoxic T cells and point to progressive (over) activation of this T cell compartment until the onset of opportunistic infections.<\/jats:p>","DOI":"10.1111\/j.1365-2249.1990.tb05395.x","type":"journal-article","created":{"date-parts":[[2010,7,26]],"date-time":"2010-07-26T17:55:18Z","timestamp":1280166918000},"page":"3-9","source":"Crossref","is-referenced-by-count":19,"title":["Evidence for circulating activated cytotoxic T cells in HIV-infected subjects before the onset of opportunistic infections"],"prefix":"10.1093","volume":"82","author":[{"given":"G","family":"VANHAM","sequence":"first","affiliation":[{"name":"Laboratory of Pathology and Immunology, Institute of Tropical Medicine, Antwerp, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"KESTENS","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology and Immunology, Institute of Tropical Medicine, Antwerp, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"GIGASE","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology and Immunology, Institute of Tropical Medicine, Antwerp, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"COLEBUNDERS","sequence":"additional","affiliation":[{"name":"Laboratory of Microbiology, Institute of Tropical Medicine, Antwerp, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"VANDENBRUAENE","sequence":"additional","affiliation":[{"name":"Laboratory of Microbiology, Institute of Tropical Medicine, Antwerp, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"BRIJ","sequence":"additional","affiliation":[{"name":"Laboratory of General Biology, Free University of Brussels, Brussels, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J L","family":"CEUPPENS","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Immunology, Faculty of Medicine, Catholic University of Leuven, Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"2022011713204154000_b1","first-page":"159","article-title":"Immune response to virusinfecled cells","volume-title":"Clinics in Immunology and Allergy","author":"Borysiewicz","year":"1986"},{"key":"2022011713204154000_b2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/jlb.46.1.75","article-title":"Natural killer cell function in patients with acquired immunodeficiency syndrome and related diseases","volume":"46","author":"Brenner","year":"1989","journal-title":"J. Leukocyte Biol."},{"key":"2022011713204154000_b3","first-page":"334","article-title":"Classification system for human T-lymphotropic virus type III\/lymphadenopathy-associated virus infections","volume":"35","author":"Centers for Disease Control","year":"1987","journal-title":"MMWR"},{"key":"2022011713204154000_b4","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/BF00917143","article-title":"Alloreactive cytotoxic T-lymphocyle precursors and effectors cells are phenotypically distinct from Leu2+ suppressor cells","volume":"4","author":"Clement","year":"1984","journal-title":"J. clin. Immunol."},{"key":"2022011713204154000_b5","doi-asserted-by":"crossref","first-page":"452","DOI":"10.4049\/jimmunol.142.2.452","article-title":"Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans","volume":"142","author":"Hoffenbach","year":"1989","journal-title":"J. Immunol."},{"key":"2022011713204154000_b6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4049\/jimmunol.135.1.5","article-title":"Lysis of anti-T3-bearing murine hybridoma cells by human allospecific cytotoxic T cell clones and inhibition of that lysis by anti-T3 and anti-LFA-1 antibodies","volume":"135","author":"Hoffman","year":"1985","journal-title":"J. Immunol."},{"key":"2022011713204154000_b7","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1365-3083.1989.tb01170.x","article-title":"Sideways killing: the cytolysis of Fc receptor-bearing cells through bridging to cytolytic T lymphocytes by antibodies specific for the T-cell receptor-T3 complex","volume":"29","author":"Ito","year":"1989","journal-title":"Scand. J. Immunol."},{"key":"2022011713204154000_b8","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0008-8749(87)90215-2","article-title":"Spontaneous human T-cell cytotoxicity against murine hybridomas expressing the OKT3 monoclonal antibody: comparison with natural killer cell activity","volume":"108","author":"Ito","year":"1987","journal-title":"Cell Immunol."},{"key":"2022011713204154000_b9","doi-asserted-by":"crossref","first-page":"8638","DOI":"10.1073\/pnas.85.22.8638","article-title":"Group-specific, major histocompatibility complex class I-restricted cytotoxic responses to human immunodeficiency virus 1 (HIV-1) envelope proteins by cloned peripheral blood T cells from an HIV-1-infected individual","volume":"85","author":"Koenig","year":"1988","journal-title":"Proc. natl Acad. Sci, USA"},{"key":"2022011713204154000_b10","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.4049\/jimmunol.141.6.1949","article-title":"Immune recognition of AIDS virus antigens by human and murine cytotoxic T lymphocytes","volume":"141","author":"Langlade-Demoyen","year":"1988","journal-title":"J. Immunol."},{"key":"2022011713204154000_b11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-3083.1985.tb01873.x","article-title":"Magnetic monosized polymer particles for fast and specific fractionation of human mononuclear cells","volume":"22","author":"Lea","year":"1985","journal-title":"Scand. J. Immunol."},{"key":"2022011713204154000_b12","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.4049\/jimmunol.134.6.3770","article-title":"Induction of nonspecific cytotoxicity by monoclonal anti-T3 antibodies","volume":"134","author":"Leeuwenberg","year":"1985","journal-title":"J. Immunol."},{"key":"2022011713204154000_b13","first-page":"471","article-title":"Natural killer cell function and modulation hy alpha IFN and IL-2 in AIDS patients and prodromal subjects","volume":"107","author":"Lew","year":"1984","journal-title":"J. Lab. clin. Med."},{"key":"2022011713204154000_b14","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4049\/jimmunol.135.1.34","article-title":"T3 monoclonal antibody activation of nonspecific cytolysis: a mechanism of CTL-inhibition","volume":"135","author":"Mentzer","year":"1985","journal-title":"J. Immunol."},{"key":"2022011713204154000_b15","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF00916936","article-title":"T cells expressing high levels of non-major histocompatibility complex (MHC)-restricted cytotoxicity are present in early and late clinical phases of human immunodeficiency virus 1 (HIV-1) infection","volume":"9","author":"Morgan","year":"1989","journal-title":"J. clin. Immunol."},{"key":"2022011713204154000_b16","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.4049\/jimmunol.143.10.3183","article-title":"Comparative studies of human FcRIII-positive and negative natural killer cells","volume":"143","author":"Nagler","year":"1989","journal-title":"J. Immunol."},{"key":"2022011713204154000_b17","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/336484a0","article-title":"HIV-I gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides","volume":"336","author":"Nixon","year":"1988","journal-title":"Nature"},{"key":"2022011713204154000_b18","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.4049\/jimmunol.136.5.1579","article-title":"Lectin-dependent and anti-CD3 induced cytotoxicity are preferentially mediated by peripheral blood cytotoxic T lymphocytes expressing Leu-7 antigen","volume":"136","author":"Phillips","year":"1986","journal-title":"J. Immunol."},{"key":"2022011713204154000_b19","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/BF00915420","article-title":"Alterations in cytotoxic and phenotypic subsets of natural killer cells in acquired immune deficiency syndrome (AIDS)","volume":"7","author":"Plaeger-Marshall","year":"1987","journal-title":"J. clin. Immunol."},{"key":"2022011713204154000_b20","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/328348a0","article-title":"AIDS virus-specific cytotoxic T lymphocytes in lung disorders","volume":"328","author":"Plata","year":"1987","journal-title":"Nature"},{"key":"2022011713204154000_b21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0167-5699(88)91212-1","article-title":"Human naive and memory T cells: reinterpretation of helper-inducer and suppressor-inducer subsets","volume":"9","author":"Sanders","year":"1988","journal-title":"Immunol. Today"},{"key":"2022011713204154000_b22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF00917128","article-title":"Enhanced peripheral blood T-cell cytotoxic in inflammatory bowel disease","volume":"9","author":"Shanahan","year":"1989","journal-title":"J. clin. Immunol."},{"key":"2022011713204154000_b23","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00002030-198804000-00007","article-title":"Human class I MHC-restricted cytotoxic T-lymphocytes specific for human immunodeficiency virus envelope antigens","volume":"2","author":"Shepp","year":"1988","journal-title":"AIDS."},{"key":"2022011713204154000_b24","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0090-1229(89)90196-7","article-title":"Lymphocyte subset analysis to predict progression to AIDS in a cohort of homosexual men in San Francisco","volume":"52","author":"Stites","year":"1989","journal-title":"Clin, Immunol. Immunapathol."},{"key":"2022011713204154000_b25","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/0008-8749(88)90103-7","article-title":"CD11 molecule defines two types of suppressor cells within the T8+ population","volume":"111","author":"Takeuchi","year":"1988","journal-title":"Cell Immunol."},{"key":"2022011713204154000_b26","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.4049\/jimmunol.139.8.2545","article-title":"Mechanism of inhibition and induction of cytolytic activity in cytotoxic T lymphocytes by CD3 monoclonal antibodies","volume":"139","author":"van Seventer","year":"1987","journal-title":"J. Immunol."},{"key":"2022011713204154000_b27","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/infdis\/157.4.851","article-title":"Natural killer cell activity as a prognostic parameter in the progression of AIDS","volume":"157","author":"Voth","year":"1988","journal-title":"J. infect. Dis."},{"key":"2022011713204154000_b28","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1089\/aid.1988.4.121","article-title":"Selective depiction of low-density CDS+, CD16+ lymphocytes during HIV infection","volume":"4","author":"Vuillier","year":"1988","journal-title":"AIDS Res. Hum. Retrorir."},{"key":"2022011713204154000_b29","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/328345a0","article-title":"HIV-specific cytotoxic T lymphocytes in seropositive individuals","volume":"328","author":"Walker","year":"1987","journal-title":"Nature"},{"key":"2022011713204154000_b30","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1126\/science.2451288","article-title":"HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals","volume":"240","author":"Walker","year":"1988","journal-title":"Science"},{"key":"2022011713204154000_b31","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00002030-199003000-00001","article-title":"Cytotoxic T lymphocytes against HIV. Editorial review","volume":"4","author":"Walker","year":"1990","journal-title":"AIDS"},{"key":"2022011713204154000_b32","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/0167-5699(88)91235-2","article-title":"Virus-triggered AIDS: a T-cell-mediated immunopalhology","volume":"9","author":"Zinkernagel","year":"1988","journal-title":"Immunol. Today."}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.1990.tb05395.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/82\/1\/3\/42217449\/j.1365-2249.1990.tb05395.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/82\/1\/3\/42217449\/j.1365-2249.1990.tb05395.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T09:56:32Z","timestamp":1685699792000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/82\/1\/3\/6488708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,10]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2008,6,28]]},"published-print":{"date-parts":[[2008,6,28]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.1990.tb05395.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[1990,10]]},"published":{"date-parts":[[1990,10]]}}}